Cite

HARVARD Citation

    Creedon, H. et al. (2014). Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer. Biochemical Society transactions. pp. 822-830. [Online]. 
  
Back to record